1 |
IMPDH2 |
Regulates NF‐kB activation and supports SARS‐CoV infection |
Non‐stress |
[75] |
2 |
TRIM56 |
Positive regulator of innate immune response. |
Non‐stress |
[78] |
3 |
ANXA1 |
Plays a vital role in TLR activation, leading to an augmentation in the type 1 IFN antiviral cytokine response; Promotes RIG‐I‐dependent signalling and apoptosis via regulation of the IRF3–IFNAR–STAT1–IFIT1 pathway in A549 lung epithelial cells. |
Non‐stress |
[80, 81] |
4 |
AP3B1 |
Required for the production of pro‐inflammatory cytokines in response to viral nucleic acids; significantly enriched in COVID‐19 patients experiencing severe cytokine storms; Crucial for the trafficking of TLR9 to specific endosomal compartments for the induction of type I interferon. |
Non‐stress |
[82, 83, 84] |
5 |
ASCC3 |
Inhibits IFN‐signalling to dampen antiviral innate immunity. |
Non‐stress |
[92] |
6 |
BAIAP2L1 |
Involved in MAVS degradation, leading to downregulation of antiviral responses. |
Non‐stress |
[93] |
7 |
HSP90B1 |
Amplifies innate and adaptive immune responses via interaction with TLR2 and TLR4 ligands. |
Non‐stress |
[85] |
8 |
PPP1CA |
Dephosphorylates RNA sensors, RIG‐I (DDX58) and MDA5 (IFIH1), to induce antiviral IFN‐b production. |
Non‐stress |
[86] |
9 |
PURA |
Regulates several human viruses that replicate in the central nervous system (CNS), including human immunodeficiency virus type I (HIV‐1) and JC virus (JCV). |
Non‐stress |
[107] |
10 |
RICTOR |
Reduces TLR4‐mediated inflammation by regulating the cellular localization of FOXO1. |
Non‐stress |
[108] |
11 |
RPL19 |
Facilitates viral multiplication in cells that express TLR3 in endosomes while inhibiting viral multiplication in cells bearing TLR3 on their cell membrane; Interacts with MIF and attenuates its pro‐inflammatory function. |
Non‐stress |
[109, 110] |
12 |
YBX1 |
Functions as a porter to lead influenza virus ribonucleoprotein complexes to microtubules; Supports the early and late stages of HIV replication. |
Non‐stress |
[94, 95] |
13 |
YY1 |
Negatively regulates TLR3‐induced expression of IFN‐b and acts downstream of TLR3 to limit the level and duration of antiviral response. |
Non‐stress |
[87] |
14 |
VCP |
Involved in the maturation of virus‐loaded endosomes |
Stress‐enhanced |
[76] |
15 |
EFTUD2 |
Novel innate immune regulator that restricts Hepatitis C virus infection through an RIG‐I/MDA5‐mediated, JAK‐STAT‐independent pathway. |
Stress‐enhanced |
[88] |
16 |
PCBP1 |
Critical in regulating MAVS degradation for both fine‐tuning antiviral immunity and preventing inflammation. |
Stress‐enhanced |
[89] |
17 |
TRIM21 |
Negatively regulates the innate immune response to intracellular double‐stranded DNA; Interacts with MAVS to positively regulate innate immunity |
Stress‐enhanced |
[111, 112] |
18 |
EIF2AK2 (PKR) |
An essential mediator of the antiviral and anti‐proliferative actions of interferon (IFN); Recruited to stress granules by G3BP1 to promote innate immune responses at both transcriptional and translational levels. |
Stress‐independent |
[23, 113] |
19 |
G3BP1 |
Inhibits RNA virus replication by positively regulating RIG‐I‐mediated cellular antiviral response; Recruits protein kinase R to promote multiple innate immune antiviral responses. |
Stress‐independent |
[23, 114, 115] |
20 |
HSPA1A |
Highly upregulated at the maternal–fetal interface during maternal COVID‐19; Mediates protective antiviral immunity in response to measles virus (MeV) brain infection. |
Stress‐independent |
[90, 91] |
21 |
LGALS1 |
Stimulates monocyte migration via the p44/42 MAP kinase pathway. |
Stress‐independent |
[116] |
22 |
NAMPT |
Activates Toll‐Like Receptor 4 to Induce NFκB signalling and inflammatory lung injury. |
Stress‐independent |
[117] |
23 |
PRKRA |
Activated by double‐stranded RNA which mediates the effects of interferon in response to viral infection. |
Stress‐independent |
[118] |
24 |
SQSTM1 |
Key intracellular target of innate defence regulator‐1 (IDR‐1). |
Stress‐independent |
[119] |
25 |
XRCC5 |
Vaccinia virus protein C16 influences the immune response by binding to the XRCC6/XRCC5 (Ku70/80) complex, thus, blocking PRKDC‐dependent DNA sensing in fibroblasts. |
Stress‐independent |
[120] |
26 |
ADAR |
A negative regulator of type I interferon‐mediated signalling pathway. |
Stress‐dependent |
[96] |
27 |
PCBP2 |
A negative regulator in MAVS‐mediated antiviral signalling; Synergizes with PCBP1 in MAVS inhibition. |
Stress‐dependent |
[89, 97] |